Investor Materials

Thumb Date Download

July 24, 2016 2016 Annual Report 4.75 MB

July 23, 2016 2015 Annual Report 5.24 MB

July 21, 2016 2014 Annual Report 2.13 MB

July 20, 2016 Corporate Presentation 1.37 MB

Recent News

Halozyme To Host First Quarter 2018 Financial Results Conference Call 04/10/18

Halozyme Announces Nomination Of Directors For Reelection At 2018 Stockholder Meeting 03/22/18

Halozyme To Present Data From Six Nonclinical Studies At American Association Of Cancer Research Annual Conference 03/14/18

Halozyme Therapeutics To Present At Upcoming Healthcare Conference 02/27/18

HALO (NASDAQ) $18.86 -0.30 -1.57% Volume: 816,952 Pricing delayed 20 minutes April 20, 2018

Jim Mazzola

Vice President, Corporate Communication & Investor Relations

Christopher Burton

Director, Investor Relations

You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.